Canada To Rethink Controversial Pricing Rules
Executive Summary
Canadian pricing body, the PMPRB, is considering relaxing screening criteria for drugs that will be subject to stricter price controls and extending grace periods for conforming with new rules.
You may also be interested in...
Pricing Reforms Prompt Canadian Business Rethink
The R&D based pharmaceutical industry would welcome changes to guidelines that will operationalize controversial new pricing regulations in Canada but industry experts say more is needed.
Canada’s Drug Pricing Reform Faces Legal Challenge
Canada’s R&D drug industry says it approached the court as a “necessary step,” given the significant impact of the pricing reforms.
Canadian Drug Pricing Reforms Could Lead To Medicine Shortages
Drug pricing reform in Canada could prompt companies to launch elsewhere or see drugs diverted to the US.